1887

Abstract

It was observed recently that recombinant yeast-derived hepatitis B surface antigen (rHBsAg) particles, which contain the S protein only, bind almost exclusively to monocytes. It is shown here that binding requires the presence of the LPS receptor CD14. Furthermore, evidence is presented that a domain on CD14 that is identical to or largely overlaps with the LPS-binding pocket is instrumental for the attachment of rHBsAg. Additionally, it is shown that the heat-labile LPS-binding protein (LBP) catalyses the binding of rHBsAg to the cells. Remarkably, natural plasma-derived HBsAg (pHBsAg) does not have this property. pHBsAg devoid of its lipids and reconstituted with phosphatidylserine or phosphatidylglycerol acquires the characteristic of yeast-derived HBsAg. Clearly, the interaction of rHBsAg with the cell membrane is determined by the presence of charged phospholipids that are absent in pHBsAg. Although a lipid–receptor interaction is suggested, antibody-inhibition experiments suggest a possible involvement of the C-terminal region of the S protein in the interaction with monocytes. The possible implications of these observations for hepatitis B virus (HBV) infection and HBV vaccine efficiency are discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-9-2279
2002-09-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/9/0832279a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-9-2279&mimeType=html&fmt=ahah

References

  1. Baijot, M. (1991). Protein arrangement in the yeast-derived hepatitis B surface antigen particles. PhD thesis, Université Catholique de Louvain, Belgium.
  2. Bazil, V. & Strominger, J. L. ( 1991; ). Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. Journal of Immunology 147, 1567-1574.
    [Google Scholar]
  3. Budkowska, A., Bedossa, P., Groh, F., Louise, A. & Pillot, J. ( 1995; ). Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. Journal of Virology 69, 840-848.
    [Google Scholar]
  4. Chen, Y.-C., Delbrook, K., Dealwis, C., Mimms, L., Mushawar, I. K. & Mandecki, W. ( 1996; ). Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proceedings of the National Academy of Sciences, USA 93, 1997-2001.[CrossRef]
    [Google Scholar]
  5. Chisari, F. V. ( 2000; ). Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. American Journal of Pathology 156, 1118-1132.
    [Google Scholar]
  6. De Falco, S., Ruvoletto, M. G., Verdoliva, A., Ruvo, M., Raucci, A., Marino, M., Senatore, S., Cassani, G., Alberti, A., Pontisso, P. & Fassina, G. ( 2001; ). Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. Journal of Biological Chemistry 276, 36613-36623.[CrossRef]
    [Google Scholar]
  7. De Meyer, S., Gong, Z., Depla, E., Maertens, G. & Yap, S. H. ( 1999; ). Involvement of phosphatidylserine and non-phospholipid components of the hepatitis B virus envelope in human Annexin V binding and in HBV infection in vitro. Journal of Hepatology 31, 783-790.[CrossRef]
    [Google Scholar]
  8. Diminsky, D., Schrimbeck, R., Reimann, J. & Barenholz, Y. ( 1997; ). Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 15, 637-647.[CrossRef]
    [Google Scholar]
  9. Diminsky, D., Moav, N., Gorecki, M. & Barenholz, Y. ( 2000; ). Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18, 3-17.[CrossRef]
    [Google Scholar]
  10. Franco, A., Paroli, M., Testa, U., Benvenuto, R., Peschle, C., Balsano, F. & Barnaba, V. ( 1992; ). Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. Journal of Experimental Medicine 175, 1095-1105.
    [Google Scholar]
  11. Ganem, D. ( 1996; ). Hepadnaviridae and their replication. In Fields Virology , pp. 2703-2738. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott–Raven.
  12. Gavilanes, F., Gonzalez-Ros, J. M. & Peterson, D. L. ( 1982; ). Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. Journal of Biological Chemistry 257, 7770-7777.
    [Google Scholar]
  13. Gavilanes, F., Gomez-Gutierrez, J., Aracil, M., Gonzalez-Ros, J. M., Ferragut, J. A., Guerrero, E. & Peterson, D. L ( 1990; ). Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components. Biochemical Journal 265, 857-864.
    [Google Scholar]
  14. Gerlich, W. H., Lu, X. & Heermann, K. H. ( 1993; ). Studies on the attachment and penetration of hepatitis B virus. Journal of Hepatology 17 (Suppl. 3), S10–S14.[CrossRef]
    [Google Scholar]
  15. Gomez-Gutierrez, J., Rodriguez-Crespo, I., Peterson, D. L. & Gavilanes, F. ( 1994; ). Reconstitution of hepatitis B surface antigen proteins into phospholipid vesicles. Biochimica et Biophysica Acta 1192, 45-52.[CrossRef]
    [Google Scholar]
  16. Gomez-Gutierrez, J., Rodriguez-Crespo, I., Peterson, D. L. & Gavilanes, F. ( 1995; ). Antigenicity of hepatitis B surface antigen proteins reconstituted with phospholipids. Biochimica et Biophysica Acta 1233, 205-212.[CrossRef]
    [Google Scholar]
  17. Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R. & Goyert, S. M. ( 1988; ). The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. Journal of Immunology 141, 547-552.
    [Google Scholar]
  18. Heijtink, R. A., Kruining, J., Bakker, M. & Schalm, S. W. ( 1985; ). Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine. Antiviral Research 8 (Suppl. 1), 273–279.
    [Google Scholar]
  19. Heijtink, R. A., van Bergen, P., Paulij, W. P., de Man, R. A. & Osterhaus, A. D. M. E. ( 2000; ). Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines. Vaccine 18, 1531-1538.[CrossRef]
    [Google Scholar]
  20. Hertogs, K., Leenders, W. P. J., Depla, E., De Bruin, W. C. C., Meheus, L., Raymackers, J., Moshage, H. & Yap, S. H. ( 1993; ). Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology 197, 549-557.[CrossRef]
    [Google Scholar]
  21. Imai, M., Yanase, Y., Nojiri, T., Miyakawa, Y. & Mayumi, M. ( 1979; ). A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 76, 242-247.
    [Google Scholar]
  22. Jack, R. S., Grunwald, U., Stelter, F., Workalemahu, G. & Schutt, C. ( 1995; ). Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. European Journal of Immunology 25, 1436-1441.[CrossRef]
    [Google Scholar]
  23. Jilg, W., Lorbeer, B., Schmidt, M., Wilske, B., Zoulek, G. & Deinhardt, F. (1984). Clinical evaluation of a recombinant hepatitis B vaccine. Lancet ii, 1174–1175.
  24. Jolivet-Reynaud, C., Lésenéchal, M., O’Donnell, B., Becquart, L., Foussadier, A., Forge, F., Battail-Poirot, N., Lacoux, X., Carman, W. & Jolivet, M. ( 2001; ). Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. Journal of Medical Virology 65, 241-249.[CrossRef]
    [Google Scholar]
  25. Kim, C. Y. & Bissell, D. M. ( 1971; ). Stability of the lipid and protein of hepatitis-associated (Australia) antigen. Journal of Infectious Diseases 123, 470-476.[CrossRef]
    [Google Scholar]
  26. Leroux-Roels, G., Cao, T., De Knibber, A., Meuleman, P., Roobrouck, A., Farhoudi, A., Vanlandschoot, P. & Desombere, I. ( 2001; ). Prevention of hepatitis B infections: vaccination and its limitation. Acta Clinica Belgica 56, 209-219.[CrossRef]
    [Google Scholar]
  27. Manesis, E. K., Cameron, C. H. & Gregoriadis, G. ( 1979; ). Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Letters 102, 107-111.[CrossRef]
    [Google Scholar]
  28. Mehdi, H., Kaplan, M. J., Anlar, F. Y., Yang, X., Bayer, R., Sutherland, K. & Peeples, M. E. ( 1994; ). Hepatitis B virus surface antigen binds to apolipoprotein H. Journal of Virology 68, 2415-2424.
    [Google Scholar]
  29. Meszaros, K., Aberle, S., White, M. & Parent, J. B. ( 1995; ). Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera. Infection and Immunity 63, 363-365.
    [Google Scholar]
  30. Neurath, A. R. & Strick, N. ( 1994; ). The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV. Virology 204, 475-477.[CrossRef]
    [Google Scholar]
  31. Neurath, A. R., Strick, N. & Sproul, P. ( 1992; ). Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. Journal of Experimental Medicine 175, 461-469.[CrossRef]
    [Google Scholar]
  32. Paulij, W. P., de Wit, P. L. M., Sünnen, C. M. G., van Roosmalen, M. H., Petersen-van Ettekoven, A., Cooreman, M. P. & Heijtink, R. A. ( 1999; ). Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. Journal of General Virology 80, 2121-2126.
    [Google Scholar]
  33. Pedron, T., Girard, R. & Chaby, R. ( 1995; ). Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes. Journal of Immunology 155, 1460-1471.
    [Google Scholar]
  34. Petit, M. A., Capel, F., Dubanchet, S. & Mabit, H. ( 1992; ). PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 187, 211-222.[CrossRef]
    [Google Scholar]
  35. Pontisso, P., Ruvoletto, M. G., Tiribelli, C., Gerlich, W. H., Ruol, A. & Alberti, A. ( 1992; ). The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. Journal of General Virology 73, 2041-2045.[CrossRef]
    [Google Scholar]
  36. Ryu, C. J., Cho, D.-Y., Gripon, P., Kim, H. S., Guguen-Guillouzo, C. & Hong, H. J. ( 2000; ). An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus. Journal of Virology 74, 110-116.[CrossRef]
    [Google Scholar]
  37. Satoh, O., Umeda, M., Imai, H., Tunoo, H. & Inoue, K. ( 1990; ). Lipid composition of hepatitis B virus surface antigen particles and the particle-producing hepatoma cell lines. Journal of Lipid Research 31, 1293-1300.
    [Google Scholar]
  38. Satoh, O., Imai, H., Yoneyama, T., Miyamura, T., Utsumi, H., Inoue, K. & Umeda, M. ( 2000; ). Membrane structure of the hepatitis B virus surface antigen particle. Biochemical Journal 127, 543-550.[CrossRef]
    [Google Scholar]
  39. Schromm, A. B., Brandenburg, K., Rietschel, E. T., Flad, H. D., Carroll, S. F. & Seydel, U. ( 1996; ). Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Letters 309, 267-271.
    [Google Scholar]
  40. Seeger, C. & Mason, W. S. ( 2000; ). Hepatitis B virus biology. Microbiology and Molecular Biology Reviews 64, 51-68.[CrossRef]
    [Google Scholar]
  41. Skelly, J., Howard, C. R. & Zuckerman, A. J. ( 1981; ). Hepatitis B polypeptide vaccine preparation in micelle form. Nature 290, 51-54.[CrossRef]
    [Google Scholar]
  42. Stefas, I., Rucheton, M., D’Angeac, A. D., Morel-Baccard, C., Seigneurin, J. M., Zarski, J. P., Martin, M., Cerutti, M., Bossy, J. P., Missé, D., Graafland, H. & Veas, F. ( 2001; ). Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology 33, 207-217.[CrossRef]
    [Google Scholar]
  43. Stelter, F., Bernheiden, M., Menzel, R., Jack, R. S., Witt, S., Fan, X., Pfister, M. & Schutt, C. ( 1997; ). Mutation of amino acids 39–44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. European Journal of Biochemistry 243, 100-109.[CrossRef]
    [Google Scholar]
  44. Stelter, F., Loppnow, H., Menzel, R., Grunwald, U., Bernheiden, M., Jack, R. S., Ulmer, A. J. & Schutt, C. ( 1999; ). Differential impact of substitution of amino acids 9–13 and 91–101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide. Journal of Immunology 163, 6035-6044.
    [Google Scholar]
  45. Stirk, H. J., Thornton, J. M. & Howard, C. R. ( 1992; ). A topological model for hepatitis B surface antigen. Intervirology 33, 148-158.
    [Google Scholar]
  46. Treichel, U., Meyer zum Buschenfelde, K. H., Stockert, R. J., Poralla, T. & Gerken, G. ( 1994; ). The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. Journal of General Virology 75, 3021-3029.[CrossRef]
    [Google Scholar]
  47. Van der Meeren, P., Van Crieckinge, W., Vanderdeelen, J. & Baert, L. ( 1994; ). Phospholipid composition of r-DNA hepatitis B surface antigens. International Journal of Pharmaceutics 106, 89-92.[CrossRef]
    [Google Scholar]
  48. Vanlandschoot, P., Beirnaert, E., Barrere, B., Calder, L., Millar, B., Wharton, S., Jou, W. M. & Fiers, W. ( 1998; ). An antibody that binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell–cell fusion but does not neutralize virus. Journal of General Virology 79, 1781-1791.
    [Google Scholar]
  49. Vanlandschoot, P., Van Houtte, F., Roobrouck, A., Farhoudi, A. & Leroux-Roels, G. ( 2002; ). Yeast-derived hepatitis B surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. Journal of General Virology 83, 1281-1289.
    [Google Scholar]
  50. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. ( 1990; ). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.[CrossRef]
    [Google Scholar]
  51. Wurfel, M. M. & Wright, S. D. ( 1997; ). Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. Journal of Immunology 158, 3925-3934.
    [Google Scholar]
  52. Yu, B., Hailman, E. & Wright, S. D. ( 1997; ). Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. Journal of Clinical Investigation 99, 315-324.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-9-2279
Loading
/content/journal/jgv/10.1099/0022-1317-83-9-2279
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error